CLINICAL_TRIALS
trial_result
· 2017-06-15
Clinical Trial Update: Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients [Phase 2]
Summary
Phase 2 study updating pharmacokinetics and optimal dosing of ertapenem in patients with end-stage renal disease undergoing hemodialysis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Corewell Health East | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED | Results posted: 2017-06-15